EMA Postpones Decision On Next Phase Of EudraVigilance To End Of 2019
Executive Summary
The European Commission has agreed to extend the ongoing signal detection pilot involving the revamped EU pharmacovigilance database and has asked for a report on experience in the first year.
You may also be interested in...
EMA Seeks To Extend EudraVigilance Pilot For Another Year
The pilot was launched to support a phased implementation of new EU requirements relating to monitoring and reporting drug safety information.
Enhanced EudraVigilance System Goes Live, EMA Updates Info For Users
After months of preparations, the European Medicines Agency’s improved pharmacovigilance database has gone live on schedule.
EU Consults On What Constitutes Personal & Commercially Confidential Data In Marketing Applications
Based on their experience with dealing with requests for access to documents over the past 12 years, EU regulators have proposed updating their guideline that provides for a harmonized approach to protecting personal data and business secrets in marketing authorization applications.